PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo. (Q47765780)

5 February 2018

title

PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo. (English)

1 reference

5 February 2018

8

Tasuku Honjo

1 reference

5 February 2018

Shunsuke Chikuma

1

1 reference

5 February 2018

Seigo Terawaki

2

1 reference

5 February 2018

Tamon Hayashi

3

1 reference

5 February 2018

Ryusuke Nabeshima

4

1 reference

5 February 2018

Takao Yoshida

5

1 reference

5 February 2018

Shiro Shibayama

6

1 reference

5 February 2018

Taku Okazaki

7

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 June 2009

1 reference

5 February 2018

published in

Journal of Immunology

1 reference

5 February 2018

volume

182

1 reference

5 February 2018

page(s)

6682-6689

1 reference

5 February 2018

issue

11

1 reference

5 February 2018

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/J.1460-2075.1992.TB05481.X

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Development of an assay to measure in vivo cytokine production in the mouse

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Induction of T cell anergy in the absence of CTLA-4/B7 interaction

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

The PD-1-PD-L pathway in immunological tolerance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Tissue expression of PD-L1 mediates peripheral T cell tolerance.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Molecular mechanisms of CD4+ T-cell anergy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

CTLA-4 is not required for induction of CD8(+) T cell anergy in vivo.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

A cell culture model for T lymphocyte clonal anergy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Signals required for programming effector and memory development by CD8+ T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.0900080

Identifiers

DOI

10.4049/JIMMUNOL.0900080

1 reference

5 February 2018

PubMed ID

19454662

1 reference

5 February 2018